Genome-wide screening of altered m6A-tagged transcript profiles in the hippocampus after traumatic brain injury in mice
- PMID: 30882247
- DOI: 10.2217/epi-2019-0002
Genome-wide screening of altered m6A-tagged transcript profiles in the hippocampus after traumatic brain injury in mice
Abstract
Aim: To systematically profile RNA m6A modification landscape after traumatic brain injury (TBI) in mice. Materials & methods: Expression of m6A-related genes was detected by quantitative real-time PCR (qPCR). Expression and location of METTL3, a key component of m6A methyltransferase complex, were determined by immunostaining. Genome-wide profiling of m6A-tagged transcripts was conducted by m6A-modified RNA immunoprecipitation sequencing (m6A-RIP-seq) and RNA sequencing (RNA-seq). Results: METTL3 was downregulated after TBI. In total, 922 m6A peaks were differentially expressed as determined by m6A-RIP-seq, with 370 upregulated and 552 downregulated. In addition, we identified differentially expressed hypomethylated and hypermethylated mRNA transcripts. Conclusion: Our data provided novel information regarding m6A modification changes in the early period of TBI, which might be promising therapy targets.
Keywords: N6-methyladenosine (m6A); hippocampus; traumatic brain injury (TBI).
Similar articles
-
M6A Methyltransferase METTL3 Modulates Traumatic Brain Injury by Targeting Ferroptosis.Front Biosci (Landmark Ed). 2025 Apr 24;30(4):31304. doi: 10.31083/FBL31304. Front Biosci (Landmark Ed). 2025. PMID: 40302332
-
Epitranscriptomic profiling of N6-methyladenosine-related RNA methylation in rat cerebral cortex following traumatic brain injury.Mol Brain. 2020 Jan 28;13(1):11. doi: 10.1186/s13041-020-0554-0. Mol Brain. 2020. PMID: 31992337 Free PMC article.
-
Identification and Characterization of N6-Methyladenosine CircRNAs and Methyltransferases in the Lens Epithelium Cells From Age-Related Cataract.Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):13. doi: 10.1167/iovs.61.10.13. Invest Ophthalmol Vis Sci. 2020. PMID: 32761139 Free PMC article.
-
The potential role of RNA N6-methyladenosine in Cancer progression.Mol Cancer. 2020 May 12;19(1):88. doi: 10.1186/s12943-020-01204-7. Mol Cancer. 2020. PMID: 32398132 Free PMC article. Review.
-
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.J Hematol Oncol. 2021 Jul 27;14(1):117. doi: 10.1186/s13045-021-01129-8. J Hematol Oncol. 2021. PMID: 34315512 Free PMC article. Review.
Cited by
-
Advances in brain epitranscriptomics research and translational opportunities.Mol Psychiatry. 2024 Feb;29(2):449-463. doi: 10.1038/s41380-023-02339-x. Epub 2023 Dec 20. Mol Psychiatry. 2024. PMID: 38123727 Free PMC article. Review.
-
Low Expression of YTH Domain-Containing 1 Promotes Microglial M1 Polarization by Reducing the Stability of Sirtuin 1 mRNA.Front Cell Neurosci. 2021 Dec 15;15:774305. doi: 10.3389/fncel.2021.774305. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34975410 Free PMC article.
-
Comprehensive analysis of transcriptome-wide m6A methylome in the anterior capsule of the lens of high myopia patients.Epigenetics. 2021 Sep;16(9):955-968. doi: 10.1080/15592294.2020.1834917. Epub 2020 Oct 27. Epigenetics. 2021. PMID: 33108260 Free PMC article.
-
m6A Modification in Mammalian Nervous System Development, Functions, Disorders, and Injuries.Front Cell Dev Biol. 2021 May 25;9:679662. doi: 10.3389/fcell.2021.679662. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34113622 Free PMC article. Review.
-
RNA modification: mechanisms and therapeutic targets.Mol Biomed. 2023 Aug 24;4(1):25. doi: 10.1186/s43556-023-00139-x. Mol Biomed. 2023. PMID: 37612540 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous